Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuantTM Microarray Based Assay. This evidence concerns the gene ERBB2 and breast cancer.